Growth Hormone Deficiency in Children Completed Phase 3 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0034025 (Growth Hormone Deficiency in Children)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04970654A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.Treatment
NCT01563926Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyTreatment
NCT01502124Safety and Efficacy of Somatropin in Children With Growth Hormone DeficiencyTreatment
NCT00262249Effect of Growth Hormone in Children With Growth Hormone DeficiencyTreatment